{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:02:43Z","timestamp":1789516963372,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Research Project of Anhui Educational Committee","award":["KJ2021ZD0087"],"award-info":[{"award-number":["KJ2021ZD0087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58916-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:52:31Z","timestamp":1782229951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NOSIP promotes cell proliferation and motility by targeting SPTAN1 for ubiquitination and degradation in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruoxue","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"58916_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina, L. et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur. Urol. 82, 529\u2013542. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019 (2022).","journal-title":"Eur. Urol."},{"key":"58916_CR2","doi-asserted-by":"publisher","unstructured":"Chowdhury, N. & Drake, C. G. Kidney Cancer: An Overview of Current Therapeutic Approaches. Urol. Clin. North. Am. 47 https:\/\/doi.org\/10.1016\/j.ucl.2020.07.009 (2020). 419\u2009\u2013\u200931.","DOI":"10.1016\/j.ucl.2020.07.009"},{"key":"58916_CR3","doi-asserted-by":"publisher","unstructured":"Petejova, N. & Martinek, A. Renal cell carcinoma: Review of etiology, pathophysiology and risk fac tors. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 160 https:\/\/doi.org\/10.5507\/bp.2015.050 (2016). 183\u2009\u2013\u200994.","DOI":"10.5507\/bp.2015.050"},{"key":"58916_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1084\/jem.20181617","volume":"215","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S., Swanton, C. & Boshoff, C. Kidney cancer: The next decade. J. Exp. Med. 215, 2477\u20132479. https:\/\/doi.org\/10.1084\/jem.20181617 (2018).","journal-title":"J. Exp. Med."},{"key":"58916_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12885-019-5291-3","volume":"19","author":"EA Evel\u00f6nn","year":"2019","unstructured":"Evel\u00f6nn, E. A. et al. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma. BMC Cancer. 19, 65. https:\/\/doi.org\/10.1186\/s12885-019-5291-3 (2019).","journal-title":"BMC Cancer"},{"key":"58916_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fgene.2019.00439","volume":"10","author":"A Mendoza-Alvarez","year":"2019","unstructured":"Mendoza-Alvarez, A. et al. Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mo rtality in Metastatic Clear Cell Kidney Carcinoma. Front. Genet. 10, 439. https:\/\/doi.org\/10.3389\/fgene.2019.00439 (2019).","journal-title":"Front. Genet."},{"key":"58916_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi, H. et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med. Res. 11, 64. https:\/\/doi.org\/10.1186\/s40779-024-00569-w (2024).","journal-title":"Mil Med. Res."},{"key":"58916_CR8","doi-asserted-by":"publisher","unstructured":"Atkins, M. B. & Tannir, N. M. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat. Rev. 70 https:\/\/doi.org\/10.1016\/j.ctrv.2018.07.009 (2018). 127\u2009\u2013\u200937.","DOI":"10.1016\/j.ctrv.2018.07.009"},{"key":"58916_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012 (2013).","journal-title":"Immunity"},{"key":"58916_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1096\/fj.00-0078com","volume":"15","author":"J Dedio","year":"2001","unstructured":"Dedio, J. et al. NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J. 15, 79\u201389. https:\/\/doi.org\/10.1096\/fj.00-0078com (2001).","journal-title":"FASEB J."},{"key":"58916_CR11","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1523\/JNEUROSCI.2265-04.2004","volume":"24","author":"J Dreyer","year":"2004","unstructured":"Dreyer, J. et al. Nitric oxide synthase (NOS)-interacting protein interacts with neurona l NOS and regulates its distribution and activity. J. Neurosci. 24, 10454\u201310465. https:\/\/doi.org\/10.1523\/JNEUROSCI.2265-04.2004 (2004).","journal-title":"J. Neurosci."},{"key":"58916_CR12","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1128\/MCB.25.18.8251-8258.2005","volume":"25","author":"M Schleicher","year":"2005","unstructured":"Schleicher, M., Brundin, F., Gross, S., M\u00fcller-Esterl, W. & Oess, S. Cell cycle-regulated inactivation of endothelial NO synthase through N OSIP-dependent targeting to the cytoskeleton. Mol. Cell. Biol. 25, 8251\u20138258. https:\/\/doi.org\/10.1128\/MCB.25.18.8251-8258.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"58916_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10735-012-9460-9","volume":"43","author":"X Yu","year":"2012","unstructured":"Yu, X. et al. Increased expression of nitric oxide synthase interacting protein (NOS IP) following traumatic spinal cord injury in rats. J. Mol. Histol. 43, 661\u2013668. https:\/\/doi.org\/10.1007\/s10735-012-9460-9 (2012).","journal-title":"J. Mol. Histol."},{"key":"58916_CR14","doi-asserted-by":"publisher","first-page":"F178","DOI":"10.1152\/ajprenal.00048.2003","volume":"285","author":"BC Kone","year":"2003","unstructured":"Kone, B. C., Kuncewicz, T., Zhang, W. & Yu, Z-Y. Protein interactions with nitric oxide synthases: controlling the righ t time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Ren. Physiol. 285, F178\u2013F190. https:\/\/doi.org\/10.1152\/ajprenal.00048.2003 (2003).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"58916_CR15","doi-asserted-by":"publisher","unstructured":"Dreyer, J., Hirlinger, D., M\u00fcller-Esterl, W., Oess, S. & Kuner, R. Spinal upregulation of the nitric oxide synthase-interacting protein N OSIP in a rat model of inflammatory pain. Neurosci. Lett. 350 https:\/\/doi.org\/10.1016\/s0304-3940(03)00771-7 (2003). 13\u2009\u2013\u20096.","DOI":"10.1016\/s0304-3940(03)00771-7"},{"key":"58916_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/gast.2002.34212","volume":"123","author":"P K\u00f6nig","year":"2002","unstructured":"K\u00f6nig, P., Dedio, J., M\u00fcller-Esterl, W. & Kummer, W. Distribution of the novel eNOS-interacting protein NOSIP in the liver, pancreas, and gastrointestinal tract of the rat. Gastroenterology 123, 314\u2013324. https:\/\/doi.org\/10.1053\/gast.2002.34212 (2002).","journal-title":"Gastroenterology"},{"key":"58916_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jpedsurg.2017.01.046","volume":"52","author":"C Tomuschat","year":"2017","unstructured":"Tomuschat, C. et al. NOS-interacting protein (NOSIP) is increased in the colon of patients with Hirschsprungs\u2019s disease. J. Pediatr. Surg. 52, 772\u2013777. https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.01.046 (2017).","journal-title":"J. Pediatr. Surg."},{"key":"58916_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1369\/jhc.4A6453.2005","volume":"53","author":"P K\u00f6nig","year":"2005","unstructured":"K\u00f6nig, P. et al. NOSIP and its interacting protein, eNOS, in the rat trachea and lung. J. Histochem. Cytochem. 53, 155\u2013164. https:\/\/doi.org\/10.1369\/jhc.4A6453.2005 (2005).","journal-title":"J. Histochem. Cytochem."},{"key":"58916_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0038-1675772","volume":"29","author":"H Nakamura","year":"2019","unstructured":"Nakamura, H., Zimmer, J., Friedmacher, F. & Puri, P. Expression of Nitric Oxide Synthase Interacting Protein (NOSIP) is Dec reased in the Pulmonary Vasculature of Nitrofen-Induced Congenital Dia phragmatic Hernia. Eur. J. Pediatr. Surg. 29, 102\u2013107. https:\/\/doi.org\/10.1055\/s-0038-1675772 (2019).","journal-title":"Eur. J. Pediatr. Surg."},{"key":"58916_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/dvdy.24659","volume":"247","author":"H Flach","year":"2018","unstructured":"Flach, H. et al. Nosip functions during vertebrate eye and cranial cartilage developmen t. Dev. Dyn. 247, 1070\u20131082. https:\/\/doi.org\/10.1002\/dvdy.24659 (2018).","journal-title":"Dev. Dyn."},{"key":"58916_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ydbio.2017.06.026","volume":"429","author":"M Hoffmeister","year":"2017","unstructured":"Hoffmeister, M. et al. Developmental neurogenesis in mouse and Xenopus is impaired in the abs ence of Nosip. Dev. Biol. 429, 200\u2013212. https:\/\/doi.org\/10.1016\/j.ydbio.2017.06.026 (2017).","journal-title":"Dev. Biol."},{"key":"58916_CR22","doi-asserted-by":"publisher","first-page":"e116150","DOI":"10.1371\/journal.pone.0116150","volume":"9","author":"M Hoffmeister","year":"2014","unstructured":"Hoffmeister, M. et al. The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activit y in craniofacial development. PLoS One. 9, e116150. https:\/\/doi.org\/10.1371\/journal.pone.0116150 (2014).","journal-title":"PLoS One"},{"key":"58916_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00436-014-3820-1","volume":"113","author":"M Bian","year":"2014","unstructured":"Bian, M. et al. Identification, immunolocalization, and immunological characterization of nitric oxide synthase-interacting protein from Clonorchis sinensis. Parasitol. Res. 113, 1749\u20131757. https:\/\/doi.org\/10.1007\/s00436-014-3820-1 (2014).","journal-title":"Parasitol. Res."},{"key":"58916_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/2211738507666190429111306","volume":"7","author":"H Alimoradi","year":"2019","unstructured":"Alimoradi, H., Greish, K., Gamble, A. B. & Giles, G. I. Controlled Delivery of Nitric Oxide for Cancer Therapy. Pharm. Nanotechnol. 7, 279\u2013303. https:\/\/doi.org\/10.2174\/2211738507666190429111306 (2019).","journal-title":"Pharm. Nanotechnol"},{"key":"58916_CR25","doi-asserted-by":"publisher","unstructured":"Kamm, A. et al. Nitric oxide and its derivatives in the cancer battlefield. Nitric Oxide. 93 https:\/\/doi.org\/10.1016\/j.niox.2019.09.005 (2019). 102\u2009\u2013\u200914.","DOI":"10.1016\/j.niox.2019.09.005"},{"key":"58916_CR26","doi-asserted-by":"publisher","first-page":"dmm033332","DOI":"10.1242\/dmm.033332","volume":"11","author":"R Keshet","year":"2018","unstructured":"Keshet, R. & Erez, A. Arginine and the metabolic regulation of nitric oxide synthesis in can cer. Dis. Model. Mech. 11, dmm033332. https:\/\/doi.org\/10.1242\/dmm.033332 (2018).","journal-title":"Dis. Model. Mech."},{"key":"58916_CR27","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.3390\/ijms21249393","volume":"21","author":"FH Khan","year":"2020","unstructured":"Khan, F. H. et al. The Role of Nitric Oxide in Cancer: Master Regulator or NOt? Int. J. Mol. Sci. 21, 9393. https:\/\/doi.org\/10.3390\/ijms21249393 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"58916_CR28","doi-asserted-by":"publisher","first-page":"119018","DOI":"10.1016\/j.bbamcr.2021.119018","volume":"1868","author":"S Sadaf","year":"2021","unstructured":"Sadaf, S. et al. nNOS induction and NOSIP interaction impact granulopoiesis and neutrop hil differentiation by modulating nitric oxide generation. Biochim. Biophys. Acta Mol. Cell. Res. 1868, 119018. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119018 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"58916_CR29","doi-asserted-by":"publisher","first-page":"23974","DOI":"10.1074\/jbc.M009307200","volume":"276","author":"WT Tse","year":"2001","unstructured":"Tse, W. T. et al. A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix. J. Biol. Chem. 276, 23974\u201323985. https:\/\/doi.org\/10.1074\/jbc.M009307200 (2001).","journal-title":"J. Biol. Chem."},{"key":"58916_CR30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1182\/blood-2011-01-330688","volume":"118","author":"S Patel-Hett","year":"2011","unstructured":"Patel-Hett, S. et al. The spectrin-based membrane skeleton stabilizes mouse megakaryocyte me mbrane systems and is essential for proplatelet and platelet formation. Blood 118, 1641\u20131652. https:\/\/doi.org\/10.1182\/blood-2011-01-330688 (2011).","journal-title":"Blood"},{"key":"58916_CR31","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1242\/jcs.080374","volume":"124","author":"MC Stankewich","year":"2011","unstructured":"Stankewich, M. C. et al. Cell organization, growth, and neural and cardiac development require \u03b1II-spectrin. J. Cell. Sci. 124, 3956\u20133966. https:\/\/doi.org\/10.1242\/jcs.080374 (2011).","journal-title":"J. Cell. Sci."},{"key":"58916_CR32","doi-asserted-by":"publisher","first-page":"16581","DOI":"10.1523\/JNEUROSCI.3332-11.2011","volume":"31","author":"Y Gao","year":"2011","unstructured":"Gao, Y. et al. \u03b2-III spectrin is critical for development of purkinje cell dendritic tree and spine morphogenesis. J. Neurosci. 31, 16581\u201316590. https:\/\/doi.org\/10.1523\/JNEUROSCI.3332-11.2011 (2011).","journal-title":"J. Neurosci."},{"key":"58916_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12031-011-9699-8","volume":"47","author":"R Kassa","year":"2012","unstructured":"Kassa, R. et al. Proximal giant neurofilamentous axonopathy in mice genetically enginee red to resist calpain and caspase cleavage of \u03b1-II spectrin. J. Mol. Neurosci. 47, 631\u2013638. https:\/\/doi.org\/10.1007\/s12031-011-9699-8 (2012).","journal-title":"J. Mol. Neurosci."},{"key":"58916_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/jcb.25123","volume":"116","author":"MW Lambert","year":"2015","unstructured":"Lambert, M. W. Functional Significance of Nuclear \u03b1 Spectrin. J. Cell. Biochem. 116, 1816\u20131830. https:\/\/doi.org\/10.1002\/jcb.25123 (2015).","journal-title":"J. Cell. Biochem."},{"key":"58916_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2009.02.038","volume":"381","author":"LW McMahon","year":"2009","unstructured":"McMahon, L. W., Zhang, P., Sridharan, D. M., Lefferts, J. A. & Lambert, M. W. Knockdown of alphaII spectrin in normal human cells by siRNA leads to chromosomal instability and decreased DNA interstrand cross-link repai r. Biochem. Biophys. Res. Commun. 381, 288\u2013293. https:\/\/doi.org\/10.1016\/j.bbrc.2009.02.038 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58916_CR36","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1038\/s41388-022-02468-7","volume":"41","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene 41, 4795\u20134807. https:\/\/doi.org\/10.1038\/s41388-022-02468-7 (2022).","journal-title":"Oncogene"},{"key":"58916_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40779-024-00533-8","volume":"11","author":"SY Wang","year":"2024","unstructured":"Wang, S. Y. et al. P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6\/IL-6R pathway. Mil Med. Res. 11, 30. https:\/\/doi.org\/10.1186\/s40779-024-00533-8 (2024).","journal-title":"Mil Med. Res."},{"key":"58916_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-023-00500-9","volume":"10","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. Mil Med. Res. 10, 64. https:\/\/doi.org\/10.1186\/s40779-023-00500-9 (2023).","journal-title":"Mil Med. Res."},{"key":"58916_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40779-023-00501-8","volume":"10","author":"HJ Xiong","year":"2023","unstructured":"Xiong, H. J. et al. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS(G12D) and drives HCC tumorigenesis via the ERK\/mTOR\/PRELID2\/ROS axis in mice. Mil Med. Res. 10, 68. https:\/\/doi.org\/10.1186\/s40779-023-00501-8 (2023).","journal-title":"Mil Med. Res."},{"key":"58916_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41419-024-06425-y","volume":"15","author":"K Chen","year":"2024","unstructured":"Chen, K. et al. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Cell. Death Dis. 15, 37. https:\/\/doi.org\/10.1038\/s41419-024-06425-y (2024).","journal-title":"Cell. Death Dis."},{"key":"58916_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41419-022-04675-2","volume":"13","author":"L Wu","year":"2022","unstructured":"Wu, L. et al. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell. Death Dis. 13, 231. https:\/\/doi.org\/10.1038\/s41419-022-04675-2 (2022).","journal-title":"Cell. Death Dis."},{"key":"58916_CR42","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/ars.2018.7527","volume":"30","author":"V Somasundaram","year":"2019","unstructured":"Somasundaram, V. et al. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Tra nsduction, and Metabolism. Antioxid. Redox Signal. 30, 1124\u20131143. https:\/\/doi.org\/10.1089\/ars.2018.7527 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"58916_CR43","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/bph.12217","volume":"169","author":"TA Heinrich","year":"2013","unstructured":"Heinrich, T. A. et al. Biological nitric oxide signalling: chemistry and terminology. Br. J. Pharmacol. 169, 1417\u20131429. https:\/\/doi.org\/10.1111\/bph.12217 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"58916_CR44","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1039\/c2cs15273h","volume":"41","author":"AW Carpenter","year":"2012","unstructured":"Carpenter, A. W. & Schoenfisch, M. H. Nitric oxide release: part II. Therapeutic applications. Chem. Soc. Rev. 41, 3742\u20133752. https:\/\/doi.org\/10.1039\/c2cs15273h (2012).","journal-title":"Chem. Soc. Rev."},{"key":"58916_CR45","doi-asserted-by":"publisher","first-page":"26851","DOI":"10.1074\/jbc.M210039200","volume":"278","author":"AD Friedman","year":"2003","unstructured":"Friedman, A. D., Nimbalkar, D. & Quelle, F. W. Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, an d require its activity for erythropoietin-induced proliferation. J. Biol. Chem. 278, 26851\u201326861. https:\/\/doi.org\/10.1074\/jbc.M210039200 (2003).","journal-title":"J. Biol. Chem."},{"key":"58916_CR46","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-019-2082-3","volume":"10","author":"H-E Zhu","year":"2019","unstructured":"Zhu, H-E., Yin, J-Y., Chen, D-X., He, S. & Chen, H. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activatin g the NO-MAPKs-PI3K\/Akt pathway. Cell. Death Dis. 10, 854. https:\/\/doi.org\/10.1038\/s41419-019-2082-3 (2019).","journal-title":"Cell. Death Dis."},{"key":"58916_CR47","doi-asserted-by":"publisher","first-page":"112524","DOI":"10.1016\/j.jep.2019.112524","volume":"250","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MT E). J. Ethnopharmacol. 250, 112524. https:\/\/doi.org\/10.1016\/j.jep.2019.112524 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"58916_CR48","doi-asserted-by":"publisher","first-page":"a018259","DOI":"10.1101\/cshperspect.a018259","volume":"8","author":"RKH Liem","year":"2016","unstructured":"Liem, R. K. H. Cytoskeletal Integrators: The Spectrin Superfamily. Cold Spring Harb Perspect. Biol. 8, a018259. https:\/\/doi.org\/10.1101\/cshperspect.a018259 (2016).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"58916_CR49","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s10038-019-0669-2","volume":"64","author":"E Leveille","year":"2019","unstructured":"Leveille, E. et al. SPTAN1 variants as a potential cause for autosomal recessive hereditar y spastic paraplegia. J. Hum. Genet. 64, 1145\u20131151. https:\/\/doi.org\/10.1038\/s10038-019-0669-2 (2019).","journal-title":"J. Hum. Genet."},{"key":"58916_CR50","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/ijms19071976","volume":"19","author":"V Rapaccini","year":"2018","unstructured":"Rapaccini, V. et al. A Child with a c.6923_6928dup (p.Arg2308_Met2309dup)\u2009<\u2009i>SPTAN1\u2009Mut ation Associated with a Severe Early Infantile Epileptic Encephalopath y. Int. J. Mol. Sci. 19, 1976. https:\/\/doi.org\/10.3390\/ijms19071976 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"58916_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1684\/epd.2018.0969","volume":"20","author":"A Aravindhan","year":"2018","unstructured":"Aravindhan, A., Shah, K., Pak, J. & Veerapandiyan, A. Early-onset epileptic encephalopathy with myoclonic seizures related t o 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes. Epileptic Disord. 20, 214\u2013218. https:\/\/doi.org\/10.1684\/epd.2018.0969 (2018).","journal-title":"Epileptic Disord"},{"key":"58916_CR52","doi-asserted-by":"publisher","first-page":"e0213411","DOI":"10.1371\/journal.pone.0213411","volume":"14","author":"A Ackermann","year":"2019","unstructured":"Ackermann, A. et al. Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer. PLoS One. 14, e0213411. https:\/\/doi.org\/10.1371\/journal.pone.0213411 (2019).","journal-title":"PLoS One"},{"key":"58916_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1476-4598-13-11","volume":"13","author":"I Hinrichsen","year":"2014","unstructured":"Hinrichsen, I. et al. Reduced migration of MLH1 deficient colon cancer cells depends on SPTA N1. Mol. Cancer. 13, 11. https:\/\/doi.org\/10.1186\/1476-4598-13-11 (2014).","journal-title":"Mol. Cancer"},{"key":"58916_CR54","doi-asserted-by":"publisher","unstructured":"Papenhausen, P. et al. Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions. Cancer Genet 231\u2013232, 1\u201313, (2019). https:\/\/doi.org\/10.1016\/j.cancergen.2018.12.002","DOI":"10.1016\/j.cancergen.2018.12.002"},{"key":"58916_CR55","doi-asserted-by":"publisher","unstructured":"Sheng, G. et al. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chro nic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq. Cancer Genet 216\u2013217, 16\u2009\u2013\u20099, (2017). https:\/\/doi.org\/10.1016\/j.cancergen.2017.05.002","DOI":"10.1016\/j.cancergen.2017.05.002"},{"key":"58916_CR56","doi-asserted-by":"publisher","first-page":"58098","DOI":"10.18632\/oncotarget.12300","volume":"8","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. MicroRNA-128-3p regulates mitomycin C-induced DNA damage response in l ung cancer cells through repressing\u2009<\u2009i>SPTAN1. Oncotarget 8, 58098\u201358107. https:\/\/doi.org\/10.18632\/oncotarget.12300 (2016).","journal-title":"Oncotarget"},{"key":"58916_CR57","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/cam4.683","volume":"5","author":"O Maeda","year":"2016","unstructured":"Maeda, O. et al. Comparison of prognoses according to non-positive and positive spectri n \u03b1II expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study. Cancer Med. 5, 1081\u20131092. https:\/\/doi.org\/10.1002\/cam4.683 (2016).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58916-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58916-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58916-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:17:54Z","timestamp":1789514274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58916-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58916"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58916-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved the institutional Review Board of Bengbu Medical University.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28835"}}